The Injecto Polymers IPO is a book-built issue of ₹56.12 crore. The issue is entirely a fresh issue of 56.12 lakh shares, aggregating to ₹56.12 crore.

The IPO bidding opened for subscription on September 11, 2026, and will close on September 16, 2026. The Injecto Polymers IPO Allotment is expected to be finalized on September 17, 2026.

The shares are proposed to be listed on the BSE SME platform, with a tentative listing date of September 21, 2026.


Injecto Polymers IPO GMP

The Injecto Polymers IPO GMP (Grey Market Premium) is an unofficial indicator that investors may track to understand market sentiment before the IPO listing. GMP represents the premium at which IPO shares are reportedly traded in the unofficial grey market.

The GMP can fluctuate based on investor demand, subscription levels, market sentiment and broader market conditions. Investors should remember that GMP is unofficial and does not guarantee the actual listing price or listing gains.

Injecto Polymers IPO Price Band and Lot Size

The Injecto Polymers IPO has fixed its price band at ₹98 to ₹100 per share. The lot size is 1,200 shares.

At the upper price band of ₹100 per share, the minimum retail application requires 2,400 shares, or 2 lots.

The minimum retail investment is:

2,400 × ₹100 = ₹2,40,000

For HNI investors, the minimum application is 3 lots, equivalent to 3,600 shares, requiring an investment of ₹3,60,000 at the upper price band.

Injecto Polymers IPO Allotment

The Injecto Polymers IPO Allotment is expected to be finalized on September 17, 2026. Investors who have applied for the IPO can check their allotment status after the basis of allotment is finalized through the IPO registrar or relevant official platforms.

Successful applicants are expected to receive the allotted shares in their demat accounts before the tentative listing date.

Injecto Polymers IPO Listing

The Injecto Polymers IPO is proposed to be listed on the BSE SME platform. The tentative listing date is September 21, 2026.

Investors should monitor the IPO subscription figures, GMP trends, company fundamentals, valuation and broader market sentiment before making an investment decision.

Injecto Polymers IPO Key Details

Particulars

Details

IPO Name

Injecto Polymers IPO

Issue Size

₹56.12 Crore

Issue Type

Book Built Issue

Fresh Issue

56.12 Lakh Shares

Price Band

₹98 – ₹100 per Share

Lot Size

1,200 Shares

Retail Application

2,400 Shares

Minimum Retail Investment

₹2,40,000

HNI Minimum Application

3 Lots / 3,600 Shares

HNI Minimum Investment

₹3,60,000

IPO Opens

September 11, 2026

IPO Closes

September 16, 2026

Allotment Date

September 17, 2026

Tentative Listing Date

September 21, 2026

Listing Platform

BSE SME

Injecto Polymers IPO GMP and Expected Listing Price

Investors often track the Injecto Polymers IPO GMP to estimate the possible listing price. A commonly used formula is:

Expected Listing Price = IPO Upper Price + GMP

For example, if the GMP is ₹X, the indicative listing price would be approximately ₹100 + ₹X.

This calculation is only for reference. GMP is unofficial and can change before listing, so the actual listing price may differ significantly.

Should You Track Injecto Polymers IPO GMP?

The Injecto Polymers IPO GMP can provide an indication of unofficial market sentiment before the listing. However, investors should not rely solely on grey market trends when evaluating the IPO.

It is important to consider the company's financial performance, valuation, business prospects, IPO objectives, subscription data, risks and prevailing market conditions before investing.

Conclusion

The Injecto Polymers IPO GMP and Allotment are important updates for investors tracking the issue ahead of its proposed BSE SME listing. With an issue size of ₹56.12 crore and a price band of ₹98 to ₹100 per share, investors may closely follow subscription trends and GMP movements during the IPO period.

While GMP can indicate unofficial market sentiment, it does not guarantee listing gains or future returns. Investors should conduct their own research and carefully evaluate the company's fundamentals and associated risks before subscribing.

Disclaimer: Injecto Polymers IPO GMP figures are unofficial and may change frequently. GMP is not regulated or guaranteed and should not be treated as an assurance of listing gains. This article is for informational purposes only and should not be considered investment advice. Investors should conduct their own research or consult a qualified financial advisor before investing.

Finowings


Post a Comment

Previous Post Next Post